High importance
Aug 21, 2026
To evaluate the efficacy of selective venous ammonia sampling-guided embolization in treating refractory hepatic encephalopathy associated with intrahepatic portovenous shunts in patients with Hereditary Hemorrhagic Telangiectasia (HHT).
The study involved patients diagnosed with HHT who presented with hepatic encephalopathy and had a large intrahepatic portovenous shunt. Selective venous ammonia sampling was performed to assess ammonia levels from different vascular territories. Based on the findings, the embolization procedure targeted the specific shunt contributing to elevated ammonia levels.
The procedure demonstrated a significant reduction in ammonia levels post-embolization, correlated with an improvement in neurologic symptoms and overall quality of life for affected patients. Follow-up evaluations indicated sustained improvement in hepatic encephalopathy symptoms in most cases.
The study is limited by its small sample size and lack of a control group, which makes it difficult to generalize the results. Long-term outcomes and effects on liver function were not comprehensively assessed, requiring further studies for validation.
This research highlights a novel approach to managing severe hepatic encephalopathy in HHT patients, offering a targeted intervention that could improve clinical outcomes. The findings may lead to new treatment protocols and inform future research aimed at optimizing care for patients suffering from complicated forms of HHT.